Bionano Genomics, Inc. (BNGO)
1.20
0.00 (0.00%)
USD |
NASDAQ |
Sep 08, 16:00
Bionano Genomics Debt to Equity Ratio : 0.2121 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.2121 |
| March 31, 2026 | 0.4542 |
| December 31, 2025 | 0.3803 |
| September 30, 2025 | 0.3453 |
| June 30, 2025 | 0.4315 |
| March 31, 2025 | 0.3821 |
| December 31, 2024 | 0.7716 |
| September 30, 2024 | 0.4595 |
| June 30, 2024 | 0.3432 |
| March 31, 2024 | 0.5186 |
| December 31, 2023 | 0.9146 |
| September 30, 2023 | 0.0852 |
| June 30, 2023 | 0.0497 |
| March 31, 2023 | 0.0483 |
| December 31, 2022 | 0.0468 |
| September 30, 2022 | 0.0369 |
| June 30, 2022 | 0.0378 |
| Date | Value |
|---|---|
| March 31, 2022 | 0.0357 |
| December 31, 2021 | 0.0317 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.041 |
| December 31, 2020 | 0.4653 |
| September 30, 2020 | 1.091 |
| June 30, 2020 | 2.692 |
| March 31, 2020 | -4.028 |
| December 31, 2019 | 5.558 |
| September 30, 2019 | -2.674 |
| June 30, 2019 | -14.44 |
| March 31, 2019 | 3.130 |
| December 31, 2018 | 0.8907 |
| September 30, 2018 | 0.5913 |
| June 30, 2018 | -1.632 |
| March 31, 2018 | -1.818 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Agilent Technologies, Inc. | 0.5363 |
| Bio-Rad Laboratories, Inc. | 0.191 |
| Bruker Corp. | 0.7663 |
| Danaher Corp. | 0.5298 |
| Harvard Bioscience, Inc. | 5.959 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 47.59M |
| Total Liabilities (Quarterly) | 15.98M |
| Shareholders Equity (Quarterly) | 31.61M |
| Current Ratio | 2.478 |
| Net Debt Paydown Yield | 17.60% |